H.I.G. Capital News
-
MARLBOROUGH, MA – September 27, 2017 - CardioFocus, Inc. today announced the European CE Mark approval of the HeartLight Excalibur Balloon, a next-generation technology designed for the treatment of atrial fibrillation (AF). The Excalibur Balloon leverages the proven universal balloon…
-
AUSTIN - August 31, 2017 - Apollo Endosurgery, Inc. (NASDAQ:APEN), a leader in less invasive surgical medical devices for bariatric and gastrointestinal procedures, announced the presentation of 20 year outcomes data for the LAP-BAND® System today at the 22nd World Congress of the…
-
August 22, 2017 - Iconic Therapeutics Appoints Brandon Smith Chief Operating Officer
SAN FRANCISCO - August 22, 2017 – Iconic Therapeutics, a clinical stage biopharmaceutical company dedicated to translating knowledge of Tissue Factor biology into new therapeutics for retinal disease and cancer, announced the appointment of Brandon Smith as Chief Operating Officer.…
-
MARLBOROUGH, MA - July 31, 2017 - CardioFocus, Inc. today announced that the Japanese Ministry of Health, Labour and Welfare has approved the HeartLight Endoscopic Ablation System for the treatment of paroxysmal atrial fibrillation (AF) in Japan. The HeartLight System is a visually…
-
July 20, 2017 - Apollo Endosurgery, Inc. Announces Pricing of $31 Million Public Offering
AUSTIN - July 20, 2017 - Apollo Endosurgery, Inc. (NASDAQ: APEN), a medical technology company primarily focused on the design, development and commercialization of innovative medical devices that can be used for the treatment of obesity, today announced the pricing of an underwritten…
-
WAYNE, PA - July 18, 2017 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized…
-
July 13, 2017 - Vertiflex, Inc. Appoints Michael Enxing to Vice President, Chief Commercial Officer
CARLSBAD, CA – July 13, 2017 – Vertiflex, Inc., a leading innovator of advanced, minimally invasive interventions for spinal stenosis, today announced the appointment of Michael Enxing as Vice President and Chief Commercial Officer. Mr. Enxing will be responsible for leading all…
-
WAYNE, PA - July 10, 2017 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE) supplemental application to modify…
-
MARLBOROUGH, MA - June 29, 2017 - CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), today announced that its HeartLight Endoscopic Ablation System is being featured in three…
-
June 26, 2017 - Clarus Re-submits Jatenzo NDA Following Positive Results of Intune Trial
NORTHBROOK, IL – June 26, 2017 - Clarus Therapeutics, Inc., today announced the re-submission of its New Drug Application (NDA) for JATENZO™ (formerly Rextoro™), the Company's oral testosterone (T) replacement product for the treatment of low testosterone in hypogonadal men, to…
-
May 4, 2017 - Apollo Endosurgery, Inc. Reports First Quarter 2017 Results
AUSTIN - May 4, 2017 - Apollo Endosurgery, Inc. ("Apollo") (NASDAQ: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced financial results for the three months ended March 31, 2017. First Quarter Highlights…
-
WAYNE, PA - May 1, 2017 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that Howard Rosen has joined its executive management team as Vice President of Marketing and Business Development. In this position,…
-
April 6, 2017 - Iconic Therapeutics Appoints Julia P. Gregory to Board of Directors
SAN FRANCISCO - April 6, 2017 – Iconic Therapeutics, a clinical stage biopharmaceutical company dedicated to translating knowledge of Tissue Factor biology into new therapeutics for retinal disease and cancer, announced today the addition of Julia P. Gregory to the company’s Board…
-
WAYNE, PA - March 23, 2017 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized…
-
March 15, 2017 - H.I.G. BioHealth Partners Invests in VertiFlex, Inc.
MIAMI – March 15, 2017 - H.I.G. BioHealth Partners (“H.I.G.”), the dedicated healthcare investment affiliate of H.I.G. Capital, a leading global private equity investment firm with $21 billion of equity capital under management,* led a $40M investment in VertiFlex, Inc. (“VertiFlex”…
-
January 17, 2017 - Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer
AUSTIN, TX – January 17, 2017 -Apollo Endosurgery, Inc. (“Apollo” or the “Company”) (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced the appointment of Christopher J. Gostout, MD, as its Chief Medical…
-
PALO ALTO, CA and RESEARCH TRIANGLE PARK, NC - Jan. 05, 2017 - Ocera Therapeutics, Inc. (NASDAQ:OCRX), today announced positive results from a Phase 1 clinical study of orally-administered OCR-002 (ornithine phenylacetate) in patients with cirrhosis. The Company is developing oral OCR-002…
-
WAYNE, PA - January 3, 2017 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that current investors New Enterprise Associates, Quaker Partners and H.I.G. BioHealth Partners have exercised their right to invest…
-
DURHAM, NC, November 14, 2016 -- HyperBranch Medical Technology, Inc. announced today that the Company has launched Adherus AutoSpray ET Dural Sealant (Extended Tip) into the United States cranial neurosurgery market. This follows approval from the United States Food and Drug Administration…